Analyst stock forecast
Cardiff Oncology Forecast: $5.81 Analyst Target
Direct answer
Cardiff Oncology's average price target is $5.81.
The target implies +343.8% from the recorded current price, and the consensus rating is Buy.
The low target implies -8.4%, the high target implies +816%, and the range spans 824.4% of the current price.
Forecast evidence checked September 23, 2026.
Get free Cardiff Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.31
- Average price target
- $5.81
- High price target
- $12.00
- Low price target
- $1.20
- Low target gap
- -8.4%
- Target upside
- +343.8%
- High target gap
- +816%
- Target range width
- 824.4%
- Consensus rating
- Buy
- Analysts
- 7
- Evidence date
- September 23, 2026
- Valid through
- September 30, 2026
Explore related company data
Read the frequently asked questions.
What is Cardiff Oncology's average price target?
Cardiff Oncology's verified average price target is $5.81. The target range is $1.20 to $12.00.
How far are Cardiff Oncology's low and high targets from the recorded price?
The low target implies -8.4%, while the high target implies +816%.
How many analysts are included in Cardiff Oncology's consensus?
The verified consensus includes 7 analysts.
How is Cardiff Oncology's target upside or downside calculated?
The average target of $5.81 is divided by the recorded price of $1.31, then one is subtracted to produce +343.8%. This does not guarantee a future return.
When was Cardiff Oncology's analyst forecast verified?
The data was verified on 2026-09-23. The dataset is valid through 2026-09-30.